Jianwei Xu, PhD
Chief Business Officer, Molecular Targeting Technologies, Inc.
Dr. Xu has a decade of consulting and investment experience in the pharmaceutical industry. Prioty to joining MTTI, he was the Cofounder and Director of Research of Zox Capital, a life science-focused hedge fund that delivered 20% yearly growth for its clients. He also founded Cambridge Solutions, a boutique consulting company that serves pharmaceutical and biotech clients on competative intelligence, strategy, and business development. Dr. Xu was trained as neuroscientist and published in prestige journals. He started his industry career as an associate at McKinsey & Company where he supported major pharmaceutical companies, planning and implementing strategies to optimize competitive position. He has identified and evaluated major trends impacting Pharmaceutical industry valuation and guides clients to exploit them to unlock value.